Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Plenary Session

Clinical

Choose Rheum
General Topic: Clinical Science

26S18: Plenary I (0772–0776)

Sunday, October 26, 2025
9:30 AM - 11:00 AM Central Time
Location: W375D-E
CE: 0.00

Non-CME In Person On Demand Choose Rheum

    Abstract Moderator(s)

  • Gregory Gardner, MD

    University of Washington
    Anacortes, Washington, United States

    Disclosure information not submitted.

  • Carol Langford, MD;MHS

    Cleveland Clinic
    Moreland Hills, Ohio, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 9:30 AM - 9:35 AM Central Time
    Rheumatology Research Foundation Corporate Roundtable Recognition

    Abstract Moderator: Liana Fraenkel, MD, MPH – Berkshire Medical Center

  • 9:35 AM - 9:45 AM Central Time
    ACR Image Competition Awards

    Abstract Moderator: Gregory Gardner, MD – University of Washington

  • 9:45 AM - 10:00 AM Central Time
    Redefining When to Biopsy the Kidney in Patients with SLE

    Presenting Author: Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine

  • 10:00 AM - 10:15 AM Central Time
    Clinical Significance of Anti-MDA5 Epitope Antibodies as Prognostic Indicators for Interstitial Lung Disease With or Without Dermatomyositis

    Presenting Author: Tsuneo Sasai, MD, PhD (he/him/his) – Kyoto University Hospital

  • 10:15 AM - 10:30 AM Central Time
    Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion

    Presenting Author: Jun Inamo, MD, PhD – University of Colorado School of Medicine

  • 10:30 AM - 10:45 AM Central Time
    Increased Circulating Microbial Small RNA tDR-1 is Associated with Decreased Progression to Future Clinical Rheumatoid Arthritis In High Risk Individuals and Reduces In Vitro Type 1 Interferon Response Gene Expression

    Presenting Author: Michelle Ormseth, MD – Vanderbilt University Medical Center

  • 10:45 AM - 11:00 AM Central Time
    Efficacy and Safety of Upadacitinib in Giant Cell Arteritis: 2-Year Results From the Re-Randomized, Double-Blind SELECT-GCA Phase 3 Trial

    Presenting Author: Wolfgang Schmidt, MD, MACR – Waldfriede Hospital Berlin, Rheumatology